MS Australia’s advocacy team regularly seeks opportunities to contribute to policy development through government or other agency reviews, consultations and inquiries via submissions.

These reviews, inquiries and consultations typically encompass proposed or existing schemes, budgets (including pre-election), planning, frameworks, policies, medicines or treatments, research funding, prices/affordability, strategies, regulations, royal commissions, standards and/or services. External bodies usually invite written submissions to address the terms of reference of the inquiry, respond to questions posed in a consultation paper or by responding to other key guidelines.

MS Australia’s submissions (sometimes presented jointly with other relevant peak organisations) include comments, concerns and recommendations on key areas that will impact on people affected by multiple sclerosis (MS) and other neurological conditions, for whom our state/territory MS member organisations provide services and support.

View our submissions for: 

Australian Human Rights Commission

Federal Government

National Disability Insurance Agency/National Disability Insurance Scheme

National Health and Medical Research Council/Medical Research Future Fund

Pharmaceutical Benefits Advisory Committee (PBAC)

Two areas of advocacy we are particularly passionate about are 1) greater access to affordable treatments for people with MS and 2) MS research.

No two cases of MS are the same and there is no one-size-fits-all treatment for the disease. MS Australia regularly makes submissions supporting the listing of MS treatments on the Pharmaceutical Benefits Scheme (PBS), so that people with MS and their neurologists have greater choice and flexibility to find the treatment method that best suits them.

Read More

Newsletter subscription

  • Enter your details